Skip to main content
. Author manuscript; available in PMC: 2018 Sep 26.
Published in final edited form as: Org Biomol Chem. 2017 Sep 26;15(37):7770–7782. doi: 10.1039/c7ob01448a

Fig.3. Structural changes in the indole (red) and sec-butyl (bue) moieties of cPT.

Fig.3

Activities shown are from HIV-1Bal.01 infection inhibition assay. The designation weak means the compound showed weak inhibition (less than 50%) at 10 μM, which was used as a cutoff point where the compound was no longer pursued.